Literature DB >> 10484615

Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice.

H Yagyu1, S Ishibashi, Z Chen, J Osuga, M Okazaki, S Perrey, T Kitamine, M Shimada, K Ohashi, K Harada, F Shionoiri, N Yahagi, T Gotoda, Y Yazaki, N Yamada.   

Abstract

Lipoprotein lipase (LPL) is known to play a crucial role in lipoprotein metabolism by hydrolyzing triglycerides; however its role in atherogenesis has yet to be determined. We have previously shown that low density lipoprotein receptor knockout mice overexpressing LPL are resistant to diet-induced atherosclerosis due to the suppression of remnant lipoproteins. Plasma lipoproteins and atherosclerosis of apolipoprotein (apo) E knockout mice which overexpress the human LPL transgene (LPL/APOEKO) were compared with those of control apoE knockout mice (APOEKO). On a normal chow diet, LPL/APOEKO mice showed marked suppression of the plasma triglyceride levels compared with APOEKO mice (54 vs. 182 mg/dl), but no significant changes in plasma cholesterol and apoB levels. Non-high density lipoproteins (HDL) from LPL/APOEKO mice had lower triglyceride content, a smaller size, and a more positive charge compared with those from APOEKO mice. Cholesterol, apoA-I, and apoA-IV were increased in HDL. Although both groups developed hypercholesterolemia to a comparable degree in response to an atherogenic diet, the LPL/APOEKO mice developed 2-fold smaller fatty streak lesions in the aortic sinus compared to the APOEKO mice. In conclusion, overproduction of LPL is protective against atherosclerosis even in the absence of apoE.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484615

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  17 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 2.  Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases.

Authors:  Werner J Geldenhuys; Li Lin; Altaf S Darvesh; Prabodh Sadana
Journal:  Drug Discov Today       Date:  2016-10-19       Impact factor: 7.851

Review 3.  Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics.

Authors:  Amit V Khera; Daniel J Rader
Journal:  Trends Cardiovasc Med       Date:  2009-08       Impact factor: 6.677

4.  The effects of simvastatin on angiogenesis: studied by an original model of atherosclerosis and acute myocardial infarction in rabbit.

Authors:  Wei Shen; Hai-Ming Shi; Wei-Hu Fan; Xin-Ping Luo; Bo Jin; Yong Li
Journal:  Mol Biol Rep       Date:  2010-11-25       Impact factor: 2.316

5.  Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity.

Authors:  Manabu Takahashi; Hiroaki Yagyu; Fumiko Tazoe; Shuichi Nagashima; Taichi Ohshiro; Kenta Okada; Jun-ichi Osuga; Ira J Goldberg; Shun Ishibashi
Journal:  J Lipid Res       Date:  2013-02-03       Impact factor: 5.922

6.  Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice.

Authors:  Chuchun L Chang; Claudia Torrejon; Un Ju Jung; Kristin Graf; Richard J Deckelbaum
Journal:  Atherosclerosis       Date:  2014-04-03       Impact factor: 5.162

7.  Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice.

Authors:  Zengxuan Nong; Herminia Gonzalez-Navarro; Marcelo Amar; Lita Freeman; Catherine Knapper; Edward B Neufeld; Beverly J Paigen; Robert F Hoyt; Jamila Fruchart-Najib; Silvia Santamarina-Fojo
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

8.  Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages.

Authors:  Ichiji Namatame; Hiroshi Tomoda; Shun Ishibashi; Satoshi Omura
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-12       Impact factor: 11.205

9.  Endothelial lipase is a major determinant of HDL level.

Authors:  Tatsuro Ishida; Sungshin Choi; Ramendra K Kundu; Ken-Ichi Hirata; Edward M Rubin; Allen D Cooper; Thomas Quertermous
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 10.  Inflammation associated with the postprandial lipolysis of triglyceride-rich lipoproteins by lipoprotein lipase.

Authors:  Laura J Higgins; John C Rutledge
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.